Concepedia

Nicolas Paquette-Lamontagne

NP

Statistics

Publications

3

Citations

148

H-Index

3

Active since

2001

Affiliations

Blueprint Medicines (United States)(Current)

KU Leuven

Charité - Universitätsmedizin Berlin

ProQR Therapeutics (Netherlands)

Nicolas Paquette-Lamontagne is an author at Blueprint Medicines (United States).

Publications per year

2001–2019

3

Publications

3

Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis

Pavel Dřevı́nek, Tacjana Pressler, Marco Cipolli et al. · Journal of Cystic Fibrosis · 2019 · 60 citations · Full text

Antisense oligonucleotide eluforsen improves CFTR function in F508del cystic fibrosis

Isabelle Sermet‐Gaudelus, John P. Clancy, David P. Nichols et al. · Journal of Cystic Fibrosis · 2018 · 53 citations · Full text

Evaluation of a New Integrated Discharge Prescription Form

Nicolas Paquette-Lamontagne, William M. McLean, Lysanne Besse et al. · Annals of Pharmacotherapy · 2001 · 35 citations

1–3 of 3